미슐랭카지노

적금만으로는 부족한 2030대 맞춤형 투자 포트폴리오 만들기

ASCO 2025: Duration of Response Following Treatment with UGN-102 in Patients with Recurrent, Low-Grade, Intermediate-Risk, Non-Muscle Invasive Bladder Cancer: 18-Month Data from the Phase 3 ENVISION Trial

UroToday

2025-05-31 07:28:23

ASCO 2025: Five-Year Follow-up Results from the Phase 3 KEYNOTE-564 Study of Adjuvant Pembrolizumab for the Treatment of Clear Cell RCC

UroToday

2025-05-31 00:37:16

A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS)

BioMed Central

2025-05-30 20:55:18

Diakonos Oncology to Present Phase I Results of Dubodencel (DOC1021), a Double-Loaded Dendritic Cell Therapy for Glioblastoma, at the ASCO 2025 Annual Meeting

FirstWord Pharma

2025-05-30 05:45:28

Phase 2 Data on Rilzabrutinib as Rescue Medication for Asthma, with William Busse, MD

HCPLive

2025-05-30 05:06:28

Norovirus vaccine produces mucosal immunity in phase 2b trial

CIDRAP

2025-05-30 05:05:00

The early dementia clue that strikes 20 years before first signs - as experts identify ‘stealth phase’

The Sun

2025-05-29 19:58:21

CMSC Poster Gives Demographic Insights for Phase 3 PERSEUS Study of Tolebrutinib

NeurologyLive

2025-05-29 19:07:09

First 'stealth phase' of Alzheimer's may strike 20 YEARS before memory fades

Daily Express

2025-05-29 13:11:00

Oral Sleep Apnea Drug Looks Promising in Phase 3 Trial

Pulmonology Advisor

2025-05-29 13:00:00

Roche to launch phase 3 trial for new antibiotic targeting Acinetobacter baumannii

CIDRAP

2025-05-29 03:23:00

First sign of dementia that can strike 20 years before disease sets in during 'stealth phase'

MSN

2025-05-29 02:31:48

KAHR Bio Announces Oral Presentation of Phase 2 Study of DSP107 in Combination with anti-PD-L1 in Colorectal Cancer at 2025 ASCO Annual Meeting

FirstWord Pharma

2025-05-28 06:12:39

Chinese-led anti-schistosomiasis mission wraps up 2nd phase in Tanzania's Zanzibar

People's Daily

2025-05-28 00:35:45

Novel Agent for Major Depression Moves to Phase III, Even With Setback

MedPage Today

2025-05-28 00:21:37

Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial

GlobeNewswire

2025-05-27 21:00:00

PEMGARDA Phase 3 Trial Shows 84% COVID-19 Prevention Efficacy in Landmark Study | IVVD Stock News

Stock Titan

2025-05-27 20:01:00

Roche moves antibiotic against superbug into Phase 3 of testing

Reuters

2025-05-27 00:44:56

Bharat Biotech Completes Phase III Trials for Hillchol Oral Cholera Vaccine Targeting Ogawa and Inaba Serotypes

geneonline.com

2025-05-27 00:07:42

적금만으로는 부족한 2030대 맞춤형 투자 포트폴리오 만들기